TVTX
Travere Therapeutics Inc

1,376
Mkt Cap
$2.75B
Volume
1.7M
52W High
$42.13
52W Low
$12.91
PE Ratio
-49.40
TVTX Fundamentals
Price
$29.79
Prev Close
$29.72
Open
$29.08
50D MA
$32.30
Beta
1.48
Avg. Volume
3.14M
EPS (Annual)
-$0.5634
P/B
23.59
Rev/Employee
$987,380.28
$3,414.72
Loading...
Loading...

About

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
497

Frequently Asked Questions

What is Market Cap of Travere Therapeutics Inc?
What is the 52-week high for Travere Therapeutics Inc?
What is the 52-week low for Travere Therapeutics Inc?
What is Travere Therapeutics Inc stock price today?
What was Travere Therapeutics Inc stock price yesterday?
What is the PE ratio of Travere Therapeutics Inc?
What is the Price-to-Book ratio of Travere Therapeutics Inc?
What is the 50-day moving average of Travere Therapeutics Inc?
How many employees does Travere Therapeutics Inc have?

Latest TVTX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.